Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ANTI-INHIBITOR COAGULANT COMPLEX

Known as: coagulation factor IX, II, VII and X in combination, Factor VIII bypassing fraction, Factor VIII inhibitor bypassing activity 
A sterile, freeze dried fraction of human plasma containing factor VIII coagulant antigen and both the inactive and active forms of coagulation… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Objectives:We report a case of a patient receiving dabigatran who developed a life-threatening bleeding complication during… Expand
Highly Cited
2012
Highly Cited
2012
Edoxaban, an oral, direct factor Xa inhibitor, has a similar or low incidence of bleeding events compared with other… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2007
Highly Cited
2007
The development of inhibitory antibodies to factor VIII is a serious complication of hemophilia. FEIBA (factor VIII inhibitor… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Highly Cited
2005
Highly Cited
2005
Summary.  In haemophilia patients with inhibitor, elective orthopaedic surgery is usually performed under recombinant activated… Expand
Review
2004
Review
2004
Summary.  Recombinant factor (rF)VIIa has been available to clinicians since 1996 and has an excellent safety record after almost… Expand
Highly Cited
2004
Highly Cited
2004
  • L. Aledort
  • Journal of thrombosis and haemostasis : JTH
  • 2004
  • Corpus ID: 34862036
Summary.  Thrombosis is a rare but well‐recognized potential complication of Factor VIII Inhibitor Bypass Activity (FEIBA… Expand
Highly Cited
2004
Highly Cited
2004
  • S. Sallah
  • Haemophilia : the official journal of the World…
  • 2004
  • Corpus ID: 816033
Summary.  Haemorrhagic manifestations in patients with acquired haemophilia can be fatal if not recognized and treated… Expand
Highly Cited
2003
Highly Cited
2003
Factor VIII (FVIII)-bypassing agents have complex modes of action but all control bleeding in inhibitor patients by triggering… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2001
Highly Cited
2001
UNLABELLED Melagatran is the active form of the oral, direct thrombin inhibitor H 376/95. In several animal models of thrombosis… Expand
Highly Cited
1997
Highly Cited
1997
Factor VIII or factor IX replacement is frequently impossible in inhibitor-developing hemophiliacs, because of the level of the… Expand